Oveporexton for Narcolepsy Type 1 - Results from Two Phase 3 Trials.

Dauvilliers Y, Mignot E, Antczak J, Arnulf I, Barateau L, Buntinx E, Corser B, Iranzo A, Khatami R, Lammers GJ, Lederer K, Nilsen KB, Pizza F, Schmidt MH, Sivam S, Sum-Ping O, Taniguchi M, Zhan S, Abraham A, Cai A, Du Y, Etherton MR, Faessel H, Hsiao S, Kadali H, Koundourakis E, Naylor M, Neuwirth R, Olsson T, Rogers R, Sheikh S, Tanaka S, von Rosenstiel P, von Hehn C, Hang Y, Yao B, Del Rio Villegas R, Plazzi G, The First Light and The Radiant Light

Open source

DOI: 10.1056/nejmoa2601598
Published: 2026 Sep 24
Container: The New England journal of medicine
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa2601598,
  title = {Oveporexton for Narcolepsy Type 1 - Results from Two Phase 3 Trials.},
  author = {Dauvilliers Y and Mignot E and Antczak J and Arnulf I and Barateau L and Buntinx E and Corser B and Iranzo A and Khatami R and Lammers GJ and Lederer K and Nilsen KB and Pizza F and Schmidt MH and Sivam S and Sum-Ping O and Taniguchi M and Zhan S and Abraham A and Cai A and Du Y and Etherton MR and Faessel H and Hsiao S and Kadali H and Koundourakis E and Naylor M and Neuwirth R and Olsson T and Rogers R and Sheikh S and Tanaka S and von Rosenstiel P and von Hehn C and Hang Y and Yao B and Del Rio Villegas R and Plazzi G and The First Light and The Radiant Light},
  year = {2026},
  journal = {The New England journal of medicine},
  doi = {10.1056/nejmoa2601598},
  url = {https://doi.org/10.1056/nejmoa2601598}
}

RIS

TY  - JOUR
TI  - Oveporexton for Narcolepsy Type 1 - Results from Two Phase 3 Trials.
AU  - Dauvilliers Y
AU  - Mignot E
AU  - Antczak J
AU  - Arnulf I
AU  - Barateau L
AU  - Buntinx E
AU  - Corser B
AU  - Iranzo A
AU  - Khatami R
AU  - Lammers GJ
AU  - Lederer K
AU  - Nilsen KB
AU  - Pizza F
AU  - Schmidt MH
AU  - Sivam S
AU  - Sum-Ping O
AU  - Taniguchi M
AU  - Zhan S
AU  - Abraham A
AU  - Cai A
AU  - Du Y
AU  - Etherton MR
AU  - Faessel H
AU  - Hsiao S
AU  - Kadali H
AU  - Koundourakis E
AU  - Naylor M
AU  - Neuwirth R
AU  - Olsson T
AU  - Rogers R
AU  - Sheikh S
AU  - Tanaka S
AU  - von Rosenstiel P
AU  - von Hehn C
AU  - Hang Y
AU  - Yao B
AU  - Del Rio Villegas R
AU  - Plazzi G
AU  - The First Light and The Radiant Light
PY  - 2026
JO  - The New England journal of medicine
DO  - 10.1056/nejmoa2601598
UR  - https://doi.org/10.1056/nejmoa2601598
ER  -

APA

Y, D., E, M., J, A., I, A., L, B., E, B., B, C., A, I., R, K., GJ, L., K, L., KB, N., F, P., MH, S., S, S., O, S., M, T., S, Z., A, A., A, C., Y, D., MR, E., H, F., S, H., H, K., E, K., M, N., R, N., T, O., R, R., S, S., S, T., P, V. R., C, V. H., Y, H., B, Y., R, D. R. V., G, P., & Light, T. F. L. A. T. R. (2026). Oveporexton for Narcolepsy Type 1 - Results from Two Phase 3 Trials.. The New England journal of medicine. https://doi.org/10.1056/nejmoa2601598

Source records

pubmed · retrieved 2026-11-10T12:37:16.416Z